Applied Therapeutics Inc (APLT)
0.7929
-0.06
(-6.89%)
USD |
NASDAQ |
Dec 26, 12:24
Applied Therapeutics Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 496.05M |
| Cassava Sciences Inc | 0.00 |
| Verastem Inc | 53.60M |
| Cellectar Biosciences Inc | 17.56M |
| Aptevo Therapeutics Inc | 4.909M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.33M |
| Free Cash Flow | -81.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1616 |
| Free Cash Flow to Equity (Quarterly) | -23.33M |
| Free Cash Flow Yield | -77.52% |